Latest Strategic Collaborations News

Parkway Corporate has teamed up with Hitachi to develop modular ultra-high brine concentration systems, crucial for its flagship Queensland Brine Management Complex project aimed at transforming industrial waste brine into green chemicals.

Prairie Lithium has begun factory acceptance testing on North America's largest commercial-scale Direct Lithium Extraction unit, aiming for Q4 2026 commissioning and first revenue under a binding Hydro Lithium offtake.

Bayan Mining and US Critical Materials have signed a non-binding MoU to develop rare-earth processing technologies licensed from the Colorado School of Mines, targeting high-grade mineralisation at the Sheep Creek Project in Montana. The collaboration aims to support a US-based rare earth supply chain with potential strategic investment on the horizon.

Amplia Therapeutics and ANZGOG have initiated a clinical trial to test narmafotinib combined with chemotherapy in ovarian cancer patients unresponsive to platinum-based treatment, aiming to improve surgical outcomes and explore biomarker insights.

Synertec Corporation has signed a non-binding MoU with Hitachi Energy to jointly develop battery energy storage systems and microgrid solutions targeting Australia’s booming energy and data centre sectors.

Great Boulder Resources has raised $40 million through a two-tranche placement to fund its acquisition of Westgold’s Peak Hill Gold Project, positioning the company for an aggressive drilling campaign and a pathway to capital light production.

Great Boulder Resources is set to acquire Westgold’s Peak Hill Gold Project for $25 million cash, a 19.9% stake, and a 1% royalty, significantly boosting its gold resources and advancing near-term production plans.

Great Boulder Resources (ASX:GBR) has struck a transformative deal to acquire Westgold’s Peak Hill Gold Project, adding nearly half a million ounces of gold resources and securing a strategic partnership to fast-track production.

Eagers Automotive has finalized its majority acquisition of CanadaOne Auto, positioning itself among the world’s largest automotive retail groups with combined pro-forma revenue nearing A$19 billion.

Noxopharm’s SOF-16 active ingredient demonstrated potent anti-inflammatory activity in patient-derived samples of systemic lupus erythematosus and rheumatoid arthritis, advancing its Sofra™ platform beyond topical applications.

Alterity Therapeutics secures FDA backing on key Phase 3 elements for ATH434 in Multiple System Atrophy, bolstered by fresh Phase 2 data showing slowed disease progression and strategic leadership hires.

Racura Oncology reported robust progress in Q3 FY2026, including launching a key lung cancer trial and unveiling a novel blood test for cardioprotection, supported by a solid $19.38 million cash position.